# NWRD09 for HPV-16 Related Cervical HSIL

> **NCT07047989** · PHASE1 · RECRUITING · sponsor: **Newish Biotech (Wuxi) Co., Ltd.** · enrollment: 9 (estimated)

## Conditions studied

- High-grade Squamous Intraepithelial Lesion (HSIL)

## Interventions

- **BIOLOGICAL:** NWRD09 injection

## Key facts

- **NCT ID:** NCT07047989
- **Lead sponsor:** Newish Biotech (Wuxi) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-12
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07047989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07047989, "NWRD09 for HPV-16 Related Cervical HSIL". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07047989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*